PINK1 and Parkinson disease: Finally, and most directly relevant to PD are findings showing that among patients with monogenic forms of illness, those in whom disease is related to PINK1 mutations are at elevated risk for neuropsychiatric symptoms, including anxiety (Ephraty et al., 2007; Kalinderi et al., 2024).